These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 3260817)
1. Isolation and characterization of cytotoxic granules from human lymphokine (interleukin 2) activated killer cells. Lowrey DM; Hameed A; Lichtenheld M; Podack ER Cancer Res; 1988 Aug; 48(16):4681-8. PubMed ID: 3260817 [TBL] [Abstract][Full Text] [Related]
2. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors. Mulé JJ; Krosnick JA; Rosenberg SA J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444 [TBL] [Abstract][Full Text] [Related]
3. Cytolytic and biochemical properties of cytoplasmic granules of murine lymphokine-activated killer cells. Henkart PA; Yue CC; Yang J; Rosenberg SA J Immunol; 1986 Oct; 137(8):2611-7. PubMed ID: 3489769 [TBL] [Abstract][Full Text] [Related]
4. IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells. DeBlaker-Hohe DF; Yamauchi A; Yu CR; Horvath-Arcidiacono JA; Bloom ET Cell Immunol; 1995 Oct; 165(1):33-43. PubMed ID: 7671323 [TBL] [Abstract][Full Text] [Related]
5. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells. Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767 [TBL] [Abstract][Full Text] [Related]
6. Ultrastructural and functional studies of the interaction between IL-12 and IL-2 for the generation of lymphokine-activated killer cells. Facchetti P; Tacchetti C; Prigione I; Airoldi I; Favre A; Grossi CE; Pistoia V Exp Cell Res; 1999 Dec; 253(2):440-53. PubMed ID: 10585267 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid. Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887 [TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12. Cesano A; Visonneau S; Clark SC; Santoli D J Immunol; 1993 Sep; 151(6):2943-57. PubMed ID: 8104216 [TBL] [Abstract][Full Text] [Related]
9. Involvement of granzyme B and perforin gene expression in the lytic potential of human natural killer cells. Clement MV; Haddad P; Soulie A; Guillet J; Sasportes M Nouv Rev Fr Hematol (1978); 1990; 32(5):349-52. PubMed ID: 2099410 [TBL] [Abstract][Full Text] [Related]
10. An anergic cytotoxic T lymphocyte clone exhibits granule exocytosis-mediated cytotoxicity. Kuwano K; Akashi A; Arai S Cell Immunol; 1998 May; 185(2):114-22. PubMed ID: 9636689 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells. Kalland T; Belfrage H; Bhiladvala P; Hedlund G J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566 [TBL] [Abstract][Full Text] [Related]
12. IL-4 regulation of perforin gene expression and BLT-esterase production in alpha CD3-induced activated killer cells. Ting CC; Liang SM; Wang J; Chen YY; Hargrove M; Xu N Biotechnol Ther; 1994-1995; 5(3-4):99-115. PubMed ID: 8608327 [TBL] [Abstract][Full Text] [Related]
13. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors. Jiang S; Persechini PM; Perussia B; Young JD J Immunol; 1989 Sep; 143(5):1453-60. PubMed ID: 2503557 [TBL] [Abstract][Full Text] [Related]
14. Modulation of perforin, granzyme A, and granzyme B in murine natural killer (NK), IL2 stimulated NK, and lymphokine-activated killer cells by alcohol consumption. Spitzer JH; Meadows GG Cell Immunol; 1999 Jun; 194(2):205-12. PubMed ID: 10383823 [TBL] [Abstract][Full Text] [Related]
15. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta. Smyth MJ; Strobl SL; Young HA; Ortaldo JR; Ochoa AC J Immunol; 1991 May; 146(10):3289-97. PubMed ID: 1827481 [TBL] [Abstract][Full Text] [Related]
16. Morphologic and functional characterization of perforin-deficient lymphokine-activated killer cells. Liu CC; Walsh CM; Eto N; Clark WR; Young JD J Immunol; 1995 Jul; 155(2):602-8. PubMed ID: 7608538 [TBL] [Abstract][Full Text] [Related]
17. Rapid loss of perforin and serine protease RNA in cytotoxic lymphocytes exposed to sensitive targets. Bajpai A; Kwon BS; Brahmi Z Immunology; 1991 Oct; 74(2):258-63. PubMed ID: 1721042 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of murine lymphokine-activated killer cell activity by retinoic acid. Lin TH; Chu TM Cancer Res; 1990 May; 50(10):3013-8. PubMed ID: 1970751 [TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin. Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]